Hypertension is one of the leading causes of death all over the world and projected to continue at the top of the list at least for the next 20 years.

Many new aspects of hypertension management were discussed during the mini-symposium. One of the speakers discussed the treatment strategies and next-level management of hypertension. The symposium expresses concern about poor hypertension control globally. Only around 39% of the women and around 30% of men with hypertension on treatment maintain their blood pressure below the target, a study concludes. The need is to improve the quality of treatment to control blood pressure as quickly as possible as it may help to avoid further complications.

The recent guidelines recommend starting the therapy with 2 drugs as compared to one in most patients. It is also important to note that there is more adherence with the single-pill combination as compared to the Free Equivalent combination. Poor adherence results in a poor outcome. It is also important to define the blood pressure target. For instance, if you want to keep the BP below 140 mm of Hg, target for a BP of around 130 mm of Hg.

It is important to also take into consideration the amount of time when the BP was under control. In a study, it was found that people who have well-controlled blood pressure over the period of 9 months to 12 months have approximately 74% reduction in the risk of myocardial infarction, stroke, and cardiovascular death. Customized treatment is also required in patients with other conditions such as diabetes. It is important to make the blood pressure management strategy in patients by identifying comorbidities and risk factors.


ESH-ISH 2021